跳至主要内容
临床试验/DRKS00027994
DRKS00027994进行中(未招募)不适用

on-interventional study of a therapeutic cannabinoid magistral preparation for chronic pain symptoms (DETECT Pain) - Detect_Pain

CannaXan GmbH0 个研究点目标入组 200 人开始时间: 2024年5月22日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
CannaXan GmbH
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1.Existing patient informed consent obtained after providing information
  • 2.Patient with a serious illness and resulting chronic pain that has not been sufficiently re-lieved by existing treatment options (cf. § 31 para. 6 SGB V)
  • 3.Moderate to severe pain: = 5 on the NRS scale (0 – 10)

排除标准

  • 1.Known history of hypersensitivity or intolerance to CannaXan 771 or its ingredients, or to ingredients of similar chemical structure
  • 2.Concurrent use of other cannabis products
  • 3.Existing substance dependence disorder (e.g., alcohol, medication, drug dependence)
  • 4.Pregnant or breastfeeding women
  • 5.Psychological illness, current or past, that precludes participation in the study
  • 6.Acute severe somatic diseases (gastrointestinal diseases, common cold)
  • 7.Severe cardiovascular diseases
  • 8.Chronic Hepatitis C or other liver or kidney disease

研究者

发起方
CannaXan GmbH

相似试验